These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 6420573)

  • 1. Chemotaxis of human polymorphonuclear leukocytes toward Neisseria gonorrhoeae.
    Rank EL; Holmes B
    J Med Microbiol; 1984 Feb; 17(1):45-52. PubMed ID: 6420573
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymorphonuclear leukocyte and monocyte chemoattractants produced by human fibroblasts.
    Sobel JD; Gallin JI
    J Clin Invest; 1979 Apr; 63(4):609-18. PubMed ID: 438325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemotactic activity of Neisseria gonorrhoeae.
    Sandström E; Venizelos N; Palmblad J
    Br J Vener Dis; 1983 Apr; 59(2):92-3. PubMed ID: 6403198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemotaxis of polymorphonuclear leukocytes from donors of different races toward Neisseria gonorrhoeae of three different auxotypes.
    Noble RC; Parekh MC; Haley JV
    Sex Transm Dis; 1985; 12(4):188-92. PubMed ID: 3936199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A specific inhibitor of complement (C5)-derived chemotactic activity in serum from patients with systemic lupus erythematosus.
    Perez HD; Lipton M; Goldstein IM
    J Clin Invest; 1978 Jul; 62(1):29-38. PubMed ID: 659635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytidine 5'-monophospho-N-acetylneuraminic acid or a related compound is the low Mr factor from human red blood cells which induces gonococcal resistance to killing by human serum.
    Nairn CA; Cole JA; Patel PV; Parsons NJ; Fox JE; Smith H
    J Gen Microbiol; 1988 Dec; 134(12):3295-306. PubMed ID: 3151997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amplification of the activity of human leukocyte inhibitory factor (LIF) by the generation of a low molecular weight inhibitor of PMN leukocyte chemotaxis.
    Goetzl EJ; Rocklin RE
    J Immunol; 1978 Sep; 121(3):891-6. PubMed ID: 690441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Partial purification of osteoclast-activating factor from phytohemagglutinin-stimulated human leukocytes.
    Luben RA; Mundy GR; Trummel CL; Raisz LG
    J Clin Invest; 1974 May; 53(5):1473-80. PubMed ID: 4825237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of methylmethacrylate on chemotaxis of polymorphonuclear leukocytes.
    Petty W
    J Bone Joint Surg Am; 1978 Jun; 60(4):492-8. PubMed ID: 353058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation of a neutrophil chemotactic agent by spermatozoa: role of complement and regulation by seminal plasma factors.
    Clark RA; Klebanoff SJ
    J Immunol; 1976 Oct; 117(4):1378-86. PubMed ID: 977954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Relationship between structure and function of a chemotactic factor for human leukocytes].
    Carletti R; Spisani S; Traniello S
    Boll Soc Ital Biol Sper; 1981 Nov; 57(22):2257-63. PubMed ID: 7326113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role for macrophage products in endotoxin-induced polymorphonuclear leukocyte accumulation during inflammation.
    Issekutz AC; Megyeri P; Issekutz TB
    Lab Invest; 1987 Jan; 56(1):49-59. PubMed ID: 3491929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of dialyzable leukocyte extracts with transfer factor activity on leukocyte migration in vitro. II. Separation and partial characterization of the components in DLE producing antigen-dependent and antigen-independent effects.
    Wilson GB; Fudenberg HH
    J Lab Clin Med; 1979 May; 93(5):819-37. PubMed ID: 429877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leukocyte chemotactic properties of soluble horny contents in epidermal cysts.
    Takematsu H; Terui T; Torinuki W; Tagami H
    Arch Dermatol Res; 1987; 279(7):449-53. PubMed ID: 3435173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Partial analysis and purification of polymorphonuclear neutrophil chemotactic inhibitors in serum from anergic patients.
    Christou NV; Meakins JL
    Arch Surg; 1983 Feb; 118(2):156-60. PubMed ID: 6849633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A neutrophil-immobilizing factor derived from human leukocytes. I. Generation and partial characterization.
    Goetzl EJ; Austen KF
    J Exp Med; 1972 Dec; 136(6):1564-80. PubMed ID: 4641855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancement of the chemotactic response of bovine polymorphonuclear leukocytes by levamisole.
    Jayappa HG; Loken KI
    Am J Vet Res; 1982 Dec; 43(12):2138-42. PubMed ID: 6762119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outer membrane proteins of Neisseria gonorrhoeae associated with survival within human polymorphonuclear phagocytes.
    Parsons NJ; Kwaasi AA; Perera VY; Patel PV; Martin PM; Smith H
    J Gen Microbiol; 1982 Dec; 128(12):3077-81. PubMed ID: 6820802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of polymorphonuclear neutrophils with Escherichia coli. Effect of enterotoxin on phagocytosis, killing, chemotaxis, and cyclic AMP.
    Bergman MJ; Guerrant RL; Murad F; Richardson SH; Weaver D; Mandell GL
    J Clin Invest; 1978 Feb; 61(2):227-34. PubMed ID: 202610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum inhibitor of C5 fragment-mediated polymorphonuclear leukocyte chemotaxis associated with chronic hemodialysis.
    Goldblum SE; Van Epps DE; Reed WP
    J Clin Invest; 1979 Jul; 64(1):255-64. PubMed ID: 447856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.